Home

"60 Minutes" (Morley Safer) Highlights Regenerative Medicine Research and Advances in the Clinic

April 6-8, 2010: Translational Regenerative Medicine Forum, Winston-Salem, NC

How Does Regenerative Medicine Fulfill the Promise of Healthcare Innovation and Personalized Medicine?

Advancing the Field through Dialogue around Scientific Discovery, Business Models and Best Practices                                                

Abstracts due January 29, 2010

Download the Call for Abstracts: Deadline for Submission January 29, 2010 ms-word pdf

The Translational Forum will feature leaders from: 
Acorda Therapeutics
Advanced BioHealing
Advanced Cell & Gene Therapy
Advanced Cell Technology
Aldagen
America Stem Cell, Inc.
ATCC
Athersys
GE Healthcare
Histogen
iPierian
Integra
Life Technologies
Novartis Institutes for Biomedical Research
Organogenesis
Pfizer
Stem Cell Therapeutics Corp.
Stratatech
Tengion
Transgeneron
DeNovo Ventures
Excel Venture Management
InterSouth Partners
Livingston Securities
Proteus Ventures
Quaker BioVentures
Safeguard Scientifics
Juvenile Diabetes Research Foundation
Fast Forward
Agency for Science, Technology and Research (A*STAR)
Armed Forces Institute for Regenerative Medicine (AFIRM)
California Institute for Regenerative Medicine (CIRM)
Harvard Stem Cell Institute
Johns Hopkins University
Northwestern University, Feinberg Neuroscience Institute
Northwestern University School of Medicine
Shanghai Jiao Tong University, School of Medicine and Shanghai 9th People’s Hospital
Tokyo Women's Medical University, Institute of Advanced Biomedical Engineering and Science
University of Kansas, Institute for Advancing Innovation
University of Miami Miller School of Medicine, Institute for Diabetes Research
University of Washington
Virginia Tech
Wake Forest Institute for Regenerative Medicine (WFIRM)
U.S. Army Medical Research
U.S. Food and Drug Administration, Center for Biologics Evaluation and Research (CBER)
National Institute for the Control of Pharmaceutical and Biological Products (SFDA)
The Aspen Institute
Center for Health Transformation
Genetics Policy Institute
Greenleaf Health, LLC
Kauffman Foundation
Hogan & Hartson
Holland & Knight
Adjuvant Global Advisors
Cell Therapy Group

NEWS
Regenerative Medicine Foundation is founding member of the Alliance for Regenerative Medicine
PR-NEWSWIRE

Welcome to the Regenerative Medicine Foundation, a not-for-profit organization created to advance new treatments and therapies based on tissue engineering and regenerative medicine. We believe that integrating life science and engineering disciplines will bring new clinical approaches to patients for the treatment of diseases affecting a wide range of tissues and organs.

By fostering collaboration between public and private initiatives, we can capitalize on the academic, industry and governmental resources in regenerative medicine and expedite the pace of research so that innovative therapies are developed and delivered to patients more rapidly. The Regenerative Medicine Foundation has been designed to be the connection point for a variety of interests, with education and interdisciplinary collaboration serving as the core and sustaining values of the organization.